These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5763976)

  • 1. Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy.
    Miller HK; Salser JS; Balis ME
    Cancer Res; 1969 Jan; 29(1):183-7. PubMed ID: 5763976
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase I study of succinylated acinetobacter L-glutaminase-L-asparaginase.
    Holcenberg JS; Camitta BM; Borella LD; Ring BJ
    Cancer Treat Rep; 1979 Jun; 63(6):1025-30. PubMed ID: 380800
    [No Abstract]   [Full Text] [Related]  

  • 3. Sensitivity to L-asparaginase and amino acid metabolism.
    Miller HK; Krakoff IH; Salser JS; Balis ME
    J Natl Cancer Inst; 1970 May; 44(5):1129-39. PubMed ID: 5514473
    [No Abstract]   [Full Text] [Related]  

  • 4. The labeling of dicarboxylic amino acids and their amides by glucose and acetate in human platelets.
    Puszkin E; Aledort L; Puszkin S
    J Lab Clin Med; 1970 Feb; 75(2):234-43. PubMed ID: 5414405
    [No Abstract]   [Full Text] [Related]  

  • 5. Theoretical and practical considerations in the use of hemodialysis for the therapeutic removal of asparagine and other amino acids.
    Riley V; Spackman DH
    Nutr Cancer; 1981; 2(3):181-92. PubMed ID: 7346782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An isocratic fluorescence HPLC assay for the monitoring of l-asparaginase activity and l-asparagine depletion in children receiving E. colil-asparaginase for the treatment of acute lymphoblastic leukaemia.
    Nath CE; Dallapozza L; Eslick AE; Misra A; Carr D; Earl JW
    Biomed Chromatogr; 2009 Feb; 23(2):152-9. PubMed ID: 18823071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of L5178Y tumor-bearing BDF1 mice with a nonimmunogenic L-glutaminase-L-asparaginase.
    Abuchowski A; van Es T; Palczuk NC; McCoy JR; Davis FF
    Cancer Treat Rep; 1979 Jun; 63(6):1127-32. PubMed ID: 466651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Amino acid concentration in plasma and blood cells during coli-L-asparaginase therapy].
    Höcker P; Stacher A; Weiser M
    Blut; 1972 Jul; 25(1):9-19. PubMed ID: 4505116
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood levels of ammonia and nitrogen scavenging amino acids in patients with inherited hyperammonemia.
    Tuchman M; Yudkoff M
    Mol Genet Metab; 1999 Jan; 66(1):10-5. PubMed ID: 9973542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful long-term use of a plasmapheresis reactor system in dogs with lymphoma.
    Dennis MB; Schmer G; Rastelli LN; Newman ML; Detter JC; Applebaum FR; Holcenberg JS
    Trans Am Soc Artif Intern Organs; 1983; 29():744-8. PubMed ID: 6143436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic properties of a new glutaminase-asparaginase preparation and the influence of the lactate dehydrogenase-elevating virus.
    Riley V; Spackman D; Fitzmaurice MA; Roberts J; Holcenberg JS; Dolowy WC
    Cancer Res; 1974 Feb; 34(2):429-38. PubMed ID: 4810909
    [No Abstract]   [Full Text] [Related]  

  • 12. Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
    Panosyan EH; Grigoryan RS; Avramis IA; Seibel NL; Gaynon PS; Siegel SE; Fingert HJ; Avramis VI
    Anticancer Res; 2004; 24(2C):1121-5. PubMed ID: 15154634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Free plasma amino acids in diabetes during acute hypoglycemia].
    Bertolini AM; Santagostino A
    Pol Tyg Lek; 1973 Apr; 28(14):496-500. PubMed ID: 4699456
    [No Abstract]   [Full Text] [Related]  

  • 14. Isotachophoretic analysis of serum for aspartic acid, asparagine, glutamic acid and glutamine.
    Robinson DV; Rimpler M
    J Clin Chem Clin Biochem; 1978 Jan; 16(1):1-4. PubMed ID: 632753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacologic studies in man with crystallized L-asparaginase (NSC-109229).
    Haskell CM; Canellos GP; Cooney DA; Hardesty CT
    Cancer Chemother Rep; 1972 Oct; 56(5):611-4. PubMed ID: 4569055
    [No Abstract]   [Full Text] [Related]  

  • 16. Polyethylene glycol-L-asparaginase and L-asparaginase studies in rabbits.
    Ho DH; Wang CY; Lin JR; Brown N; Newman RA; Krakoff IH
    Drug Metab Dispos; 1988; 16(1):27-9. PubMed ID: 2894951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acids and L-asparaginase activity in the plasma of owl monkeys (Aotus trivirgatus).
    Peters JH; Smith CC
    J Med Primatol; 1972; 1(5):326-32. PubMed ID: 4633138
    [No Abstract]   [Full Text] [Related]  

  • 18. [Letter: Comparison of biological properties of 2 preparations: L-asparaginase and L-amidohydrolase].
    Pienkowska K; Koziorowska J
    Acta Pol Pharm; 1975; 32(4):513-4. PubMed ID: 1163264
    [No Abstract]   [Full Text] [Related]  

  • 19. Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).
    Grigoryan RS; Panosyan EH; Seibel NL; Gaynon PS; Avramis IA; Avramis VI
    In Vivo; 2004; 18(2):107-12. PubMed ID: 15113036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid levels and L-asparaginase and histaminase activities in plasma of the armadillo, Dasypus novemcinctus.
    Peters JH; Storrs EE
    Lab Anim Sci; 1972 Apr; 22(2):233-6. PubMed ID: 4336995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.